# Cefazolin

NDC: 67184-1001
Generic name: Cefazolin
Labeler / Manufacturer: Qilu Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20151228

FDA application: ANDA203661

## Active ingredients

- CEFAZOLIN SODIUM: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67184-1001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67184-1001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8bd9e95-8af5-416b-b58c-e1dbe3d052ac